Chapter

Health insurance and the uptake of new drugs in the United States

Marin Gemmill, Victoria Serra-Sastre and Joan Costa-Font

in The Economics of New Health Technologies

Published in print May 2009 | ISBN: 9780199550685
Published online February 2010 | e-ISBN: 9780191720543 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199550685.003.0007
 Health insurance and the uptake of new drugs in the United States

Show Summary Details

Preview

This chapter investigates the effect of health insurance coverage on the use of relatively new prescription drugs. It focuses on statins, a class of lipid-lowering drugs that were considered a major breakthrough after a number of important clinical trials were published. The chapter is organized as follows: Section 2firstly it briefly reviews the literature on technology diffusion and the relationship between insurance and consumption, and also covers the institutional setting in the United States. Next it offers a model of pharmaceutical adoption. The next section provides the results of the analysis. Finally it concludes with a discussion of the results and the policy implications.

Keywords: health insurance coverage; drug use; new prescription drugs; statins; technology diffusion

Chapter.  6423 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.